Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1862201
PUBLISHER: QYResearch | PRODUCT CODE: 1862201
Natural Killer Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
PUBLISHED:
PAGES: 102 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global market for Natural Killer Cell Therapy was estimated to be worth US$ 484 million in 2024 and is forecast to a readjusted size of US$ 1568 million by 2031 with a CAGR of 18.2% during the forecast period 2025-2031.
Natural killer (NK) cell therapy is an emerging form of immunotherapy that utilizes the innate immune system's natural killer cells to identify and destroy cancer cells or virally infected cells. NK cells are a type of lymphocyte capable of recognizing abnormal cells without prior sensitization, distinguishing them from normal healthy cells. In NK cell therapy, NK cells may be derived from the patient (autologous) or a donor (allogeneic), and can be expanded and activated in vitro before being infused into the patient. This therapy is being investigated for use in a range of cancers, including leukemia, lymphoma, and solid tumors, as well as in some infectious diseases.
The market for natural killer (NK) cell therapy is gaining significant momentum as part of the broader expansion of cellular immunotherapies. Unlike T-cell-based therapies, NK cell therapies offer advantages such as lower risk of graft-versus-host disease, shorter preparation time, and the potential for off-the-shelf products. These features have attracted interest from biotech companies, pharmaceutical firms, and academic research institutions. Numerous clinical trials are underway across North America, Europe, and Asia, exploring the efficacy of NK cell therapy in treating both hematologic malignancies and solid tumors. The combination of NK cells with other immunotherapies or genetic modifications, such as CAR-NK (chimeric antigen receptor-modified NK cells), is also showing promising results.
Key factors driving the market include increasing cancer incidence, growing investment in cell-based therapies, and advancements in NK cell expansion and engineering technologies. However, challenges remain, such as the limited persistence of NK cells in vivo and the complexity of large-scale manufacturing. Despite these hurdles, the outlook for the NK cell therapy market is optimistic, with strong support from regulatory agencies and continued scientific progress. As the demand for safer and more effective cancer treatments rises, NK cell therapy is expected to become a critical component of next-generation immuno-oncology strategies.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Natural Killer Cell Therapy by region & country, by Type, and by Application.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
Market Segmentation
By Company
- Nektar Therapeutics
- ImmunityBio, Inc
- GC Cell
- Affimed
- Innate Pharma SA
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Nkarta Therapeutics
- Fortress Biotech
- Nkure
Segment by Type
- NK Cell Therapy
- CAR-NK Cell Therapy
Segment by Application
- Cancer
- Infectious Diseases
- Gastrointestinal Diseases
- Beauty and Anti-Aging
- Others
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Natural Killer Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Natural Killer Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Natural Killer Cell Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Natural Killer Cell Therapy Product Introduction
- 1.2 Global Natural Killer Cell Therapy Market Size Forecast (2020-2031)
- 1.3 Natural Killer Cell Therapy Market Trends & Drivers
- 1.3.1 Natural Killer Cell Therapy Industry Trends
- 1.3.2 Natural Killer Cell Therapy Market Drivers & Opportunity
- 1.3.3 Natural Killer Cell Therapy Market Challenges
- 1.3.4 Natural Killer Cell Therapy Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Natural Killer Cell Therapy Players Revenue Ranking (2024)
- 2.2 Global Natural Killer Cell Therapy Revenue by Company (2020-2025)
- 2.3 Key Companies Natural Killer Cell Therapy Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Natural Killer Cell Therapy Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Natural Killer Cell Therapy
- 2.6 Natural Killer Cell Therapy Market Competitive Analysis
- 2.6.1 Natural Killer Cell Therapy Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Natural Killer Cell Therapy Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 NK Cell Therapy
- 3.1.2 CAR-NK Cell Therapy
- 3.2 Global Natural Killer Cell Therapy Sales Value by Type
- 3.2.1 Global Natural Killer Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Natural Killer Cell Therapy Sales Value, by Type (2020-2031)
- 3.2.3 Global Natural Killer Cell Therapy Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Cancer
- 4.1.2 Infectious Diseases
- 4.1.3 Gastrointestinal Diseases
- 4.1.4 Beauty and Anti-Aging
- 4.1.5 Others
- 4.2 Global Natural Killer Cell Therapy Sales Value by Application
- 4.2.1 Global Natural Killer Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Natural Killer Cell Therapy Sales Value, by Application (2020-2031)
- 4.2.3 Global Natural Killer Cell Therapy Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Natural Killer Cell Therapy Sales Value by Region
- 5.1.1 Global Natural Killer Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Natural Killer Cell Therapy Sales Value by Region (2020-2025)
- 5.1.3 Global Natural Killer Cell Therapy Sales Value by Region (2026-2031)
- 5.1.4 Global Natural Killer Cell Therapy Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Natural Killer Cell Therapy Sales Value, 2020-2031
- 5.2.2 North America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Natural Killer Cell Therapy Sales Value, 2020-2031
- 5.3.2 Europe Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Natural Killer Cell Therapy Sales Value, 2020-2031
- 5.4.2 Asia Pacific Natural Killer Cell Therapy Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Natural Killer Cell Therapy Sales Value, 2020-2031
- 5.5.2 South America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Natural Killer Cell Therapy Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Natural Killer Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.3.2 United States Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.4.2 Europe Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.5.2 China Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.6.2 Japan Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.7.2 South Korea Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.8.2 Southeast Asia Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Natural Killer Cell Therapy Sales Value, 2020-2031
- 6.9.2 India Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Nektar Therapeutics
- 7.1.1 Nektar Therapeutics Profile
- 7.1.2 Nektar Therapeutics Main Business
- 7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- 7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.1.5 Nektar Therapeutics Recent Developments
- 7.2 ImmunityBio, Inc
- 7.2.1 ImmunityBio, Inc Profile
- 7.2.2 ImmunityBio, Inc Main Business
- 7.2.3 ImmunityBio, Inc Natural Killer Cell Therapy Products, Services and Solutions
- 7.2.4 ImmunityBio, Inc Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.2.5 ImmunityBio, Inc Recent Developments
- 7.3 GC Cell
- 7.3.1 GC Cell Profile
- 7.3.2 GC Cell Main Business
- 7.3.3 GC Cell Natural Killer Cell Therapy Products, Services and Solutions
- 7.3.4 GC Cell Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.3.5 GC Cell Recent Developments
- 7.4 Affimed
- 7.4.1 Affimed Profile
- 7.4.2 Affimed Main Business
- 7.4.3 Affimed Natural Killer Cell Therapy Products, Services and Solutions
- 7.4.4 Affimed Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.4.5 Affimed Recent Developments
- 7.5 Innate Pharma SA
- 7.5.1 Innate Pharma SA Profile
- 7.5.2 Innate Pharma SA Main Business
- 7.5.3 Innate Pharma SA Natural Killer Cell Therapy Products, Services and Solutions
- 7.5.4 Innate Pharma SA Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.5.5 Innate Pharma SA Recent Developments
- 7.6 Fate Therapeutics
- 7.6.1 Fate Therapeutics Profile
- 7.6.2 Fate Therapeutics Main Business
- 7.6.3 Fate Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- 7.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.6.5 Fate Therapeutics Recent Developments
- 7.7 Glycostem Therapeutics
- 7.7.1 Glycostem Therapeutics Profile
- 7.7.2 Glycostem Therapeutics Main Business
- 7.7.3 Glycostem Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- 7.7.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.7.5 Glycostem Therapeutics Recent Developments
- 7.8 Dragonfly Therapeutics
- 7.8.1 Dragonfly Therapeutics Profile
- 7.8.2 Dragonfly Therapeutics Main Business
- 7.8.3 Dragonfly Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- 7.8.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.8.5 Dragonfly Therapeutics Recent Developments
- 7.9 Nkarta Therapeutics
- 7.9.1 Nkarta Therapeutics Profile
- 7.9.2 Nkarta Therapeutics Main Business
- 7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- 7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.9.5 Nkarta Therapeutics Recent Developments
- 7.10 Fortress Biotech
- 7.10.1 Fortress Biotech Profile
- 7.10.2 Fortress Biotech Main Business
- 7.10.3 Fortress Biotech Natural Killer Cell Therapy Products, Services and Solutions
- 7.10.4 Fortress Biotech Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.10.5 Fortress Biotech Recent Developments
- 7.11 Nkure
- 7.11.1 Nkure Profile
- 7.11.2 Nkure Main Business
- 7.11.3 Nkure Natural Killer Cell Therapy Products, Services and Solutions
- 7.11.4 Nkure Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.11.5 Nkure Recent Developments
8 Industry Chain Analysis
- 8.1 Natural Killer Cell Therapy Industrial Chain
- 8.2 Natural Killer Cell Therapy Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Natural Killer Cell Therapy Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Natural Killer Cell Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. Natural Killer Cell Therapy Market Trends
- Table 2. Natural Killer Cell Therapy Market Drivers & Opportunity
- Table 3. Natural Killer Cell Therapy Market Challenges
- Table 4. Natural Killer Cell Therapy Market Restraints
- Table 5. Global Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global Natural Killer Cell Therapy Revenue Market Share by Company (2020-2025)
- Table 7. Key Companies Natural Killer Cell Therapy Manufacturing Base Distribution and Headquarters
- Table 8. Key Companies Natural Killer Cell Therapy Product Type
- Table 9. Key Companies Time to Begin Mass Production of Natural Killer Cell Therapy
- Table 10. Global Natural Killer Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
- Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
- Table 12. Mergers & Acquisitions, Expansion Plans
- Table 13. Global Natural Killer Cell Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 14. Global Natural Killer Cell Therapy Sales Value by Type (2020-2025) & (US$ Million)
- Table 15. Global Natural Killer Cell Therapy Sales Value by Type (2026-2031) & (US$ Million)
- Table 16. Global Natural Killer Cell Therapy Sales Market Share in Value by Type (2020-2025)
- Table 17. Global Natural Killer Cell Therapy Sales Market Share in Value by Type (2026-2031)
- Table 18. Global Natural Killer Cell Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 19. Global Natural Killer Cell Therapy Sales Value by Application (2020-2025) & (US$ Million)
- Table 20. Global Natural Killer Cell Therapy Sales Value by Application (2026-2031) & (US$ Million)
- Table 21. Global Natural Killer Cell Therapy Sales Market Share in Value by Application (2020-2025)
- Table 22. Global Natural Killer Cell Therapy Sales Market Share in Value by Application (2026-2031)
- Table 23. Global Natural Killer Cell Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 24. Global Natural Killer Cell Therapy Sales Value by Region (2020-2025) & (US$ Million)
- Table 25. Global Natural Killer Cell Therapy Sales Value by Region (2026-2031) & (US$ Million)
- Table 26. Global Natural Killer Cell Therapy Sales Value by Region (2020-2025) & (%)
- Table 27. Global Natural Killer Cell Therapy Sales Value by Region (2026-2031) & (%)
- Table 28. Key Countries/Regions Natural Killer Cell Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 29. Key Countries/Regions Natural Killer Cell Therapy Sales Value, (2020-2025) & (US$ Million)
- Table 30. Key Countries/Regions Natural Killer Cell Therapy Sales Value, (2026-2031) & (US$ Million)
- Table 31. Nektar Therapeutics Basic Information List
- Table 32. Nektar Therapeutics Description and Business Overview
- Table 33. Nektar Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- Table 34. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Nektar Therapeutics (2020-2025)
- Table 35. Nektar Therapeutics Recent Developments
- Table 36. ImmunityBio, Inc Basic Information List
- Table 37. ImmunityBio, Inc Description and Business Overview
- Table 38. ImmunityBio, Inc Natural Killer Cell Therapy Products, Services and Solutions
- Table 39. Revenue (US$ Million) in Natural Killer Cell Therapy Business of ImmunityBio, Inc (2020-2025)
- Table 40. ImmunityBio, Inc Recent Developments
- Table 41. GC Cell Basic Information List
- Table 42. GC Cell Description and Business Overview
- Table 43. GC Cell Natural Killer Cell Therapy Products, Services and Solutions
- Table 44. Revenue (US$ Million) in Natural Killer Cell Therapy Business of GC Cell (2020-2025)
- Table 45. GC Cell Recent Developments
- Table 46. Affimed Basic Information List
- Table 47. Affimed Description and Business Overview
- Table 48. Affimed Natural Killer Cell Therapy Products, Services and Solutions
- Table 49. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Affimed (2020-2025)
- Table 50. Affimed Recent Developments
- Table 51. Innate Pharma SA Basic Information List
- Table 52. Innate Pharma SA Description and Business Overview
- Table 53. Innate Pharma SA Natural Killer Cell Therapy Products, Services and Solutions
- Table 54. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Innate Pharma SA (2020-2025)
- Table 55. Innate Pharma SA Recent Developments
- Table 56. Fate Therapeutics Basic Information List
- Table 57. Fate Therapeutics Description and Business Overview
- Table 58. Fate Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- Table 59. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Fate Therapeutics (2020-2025)
- Table 60. Fate Therapeutics Recent Developments
- Table 61. Glycostem Therapeutics Basic Information List
- Table 62. Glycostem Therapeutics Description and Business Overview
- Table 63. Glycostem Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- Table 64. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Glycostem Therapeutics (2020-2025)
- Table 65. Glycostem Therapeutics Recent Developments
- Table 66. Dragonfly Therapeutics Basic Information List
- Table 67. Dragonfly Therapeutics Description and Business Overview
- Table 68. Dragonfly Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- Table 69. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Dragonfly Therapeutics (2020-2025)
- Table 70. Dragonfly Therapeutics Recent Developments
- Table 71. Nkarta Therapeutics Basic Information List
- Table 72. Nkarta Therapeutics Description and Business Overview
- Table 73. Nkarta Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
- Table 74. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Nkarta Therapeutics (2020-2025)
- Table 75. Nkarta Therapeutics Recent Developments
- Table 76. Fortress Biotech Basic Information List
- Table 77. Fortress Biotech Description and Business Overview
- Table 78. Fortress Biotech Natural Killer Cell Therapy Products, Services and Solutions
- Table 79. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Fortress Biotech (2020-2025)
- Table 80. Fortress Biotech Recent Developments
- Table 81. Nkure Basic Information List
- Table 82. Nkure Description and Business Overview
- Table 83. Nkure Natural Killer Cell Therapy Products, Services and Solutions
- Table 84. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Nkure (2020-2025)
- Table 85. Nkure Recent Developments
- Table 86. Key Raw Materials Lists
- Table 87. Raw Materials Key Suppliers Lists
- Table 88. Natural Killer Cell Therapy Downstream Customers
- Table 89. Natural Killer Cell Therapy Distributors List
- Table 90. Research Programs/Design for This Report
- Table 91. Key Data Information from Secondary Sources
- Table 92. Key Data Information from Primary Sources
List of Figures
- Figure 1. Natural Killer Cell Therapy Product Picture
- Figure 2. Global Natural Killer Cell Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global Natural Killer Cell Therapy Sales Value (2020-2031) & (US$ Million)
- Figure 4. Natural Killer Cell Therapy Report Years Considered
- Figure 5. Global Natural Killer Cell Therapy Players Revenue Ranking (2024) & (US$ Million)
- Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Natural Killer Cell Therapy Revenue in 2024
- Figure 7. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 8. NK Cell Therapy Picture
- Figure 9. CAR-NK Cell Therapy Picture
- Figure 10. Global Natural Killer Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 11. Global Natural Killer Cell Therapy Sales Value Market Share by Type, 2024 & 2031
- Figure 12. Product Picture of Cancer
- Figure 13. Product Picture of Infectious Diseases
- Figure 14. Product Picture of Gastrointestinal Diseases
- Figure 15. Product Picture of Beauty and Anti-Aging
- Figure 16. Product Picture of Others
- Figure 17. Global Natural Killer Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 18. Global Natural Killer Cell Therapy Sales Value Market Share by Application, 2024 & 2031
- Figure 19. North America Natural Killer Cell Therapy Sales Value (2020-2031) & (US$ Million)
- Figure 20. North America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 21. Europe Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 22. Europe Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 23. Asia Pacific Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 24. Asia Pacific Natural Killer Cell Therapy Sales Value by Region (%), 2024 VS 2031
- Figure 25. South America Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 26. South America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 27. Middle East & Africa Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 28. Middle East & Africa Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 29. Key Countries/Regions Natural Killer Cell Therapy Sales Value (%), (2020-2031)
- Figure 30. United States Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 31. United States Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 32. United States Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 33. Europe Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 34. Europe Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 35. Europe Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 36. China Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 37. China Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 38. China Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 39. Japan Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 40. Japan Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 41. Japan Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 42. South Korea Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 43. South Korea Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 44. South Korea Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 45. Southeast Asia Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 46. Southeast Asia Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 47. Southeast Asia Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 48. India Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 49. India Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 50. India Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 51. Natural Killer Cell Therapy Industrial Chain
- Figure 52. Natural Killer Cell Therapy Manufacturing Cost Structure
- Figure 53. Channels of Distribution (Direct Sales, and Distribution)
- Figure 54. Bottom-up and Top-down Approaches for This Report
- Figure 55. Data Triangulation
- Figure 56. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.